RU2013123062A - Цистеин и потребление пищи - Google Patents

Цистеин и потребление пищи Download PDF

Info

Publication number
RU2013123062A
RU2013123062A RU2013123062/15A RU2013123062A RU2013123062A RU 2013123062 A RU2013123062 A RU 2013123062A RU 2013123062/15 A RU2013123062/15 A RU 2013123062/15A RU 2013123062 A RU2013123062 A RU 2013123062A RU 2013123062 A RU2013123062 A RU 2013123062A
Authority
RU
Russia
Prior art keywords
cysteine
use according
nutritional composition
food
nutritional
Prior art date
Application number
RU2013123062/15A
Other languages
English (en)
Russian (ru)
Inventor
Дени БРЁЙЕ
Изабель ПАПЕ
Карин ВИДАЛЬ
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43304791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2013123062(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of RU2013123062A publication Critical patent/RU2013123062A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2013123062/15A 2010-10-21 2011-10-19 Цистеин и потребление пищи RU2013123062A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10188399.9 2010-10-21
EP10188399A EP2444083A1 (en) 2010-10-21 2010-10-21 Cysteine and food intake
PCT/EP2011/068231 WO2012052463A1 (en) 2010-10-21 2011-10-19 Cysteine and food intake

Publications (1)

Publication Number Publication Date
RU2013123062A true RU2013123062A (ru) 2014-11-27

Family

ID=43304791

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013123062/15A RU2013123062A (ru) 2010-10-21 2011-10-19 Цистеин и потребление пищи

Country Status (15)

Country Link
US (1) US9233090B2 (enExample)
EP (2) EP2444083A1 (enExample)
JP (1) JP6160832B2 (enExample)
CN (1) CN103269697A (enExample)
AU (1) AU2011317627B2 (enExample)
BR (1) BR112013009709A2 (enExample)
CA (1) CA2815109C (enExample)
DK (1) DK2629769T3 (enExample)
ES (1) ES2654344T3 (enExample)
MX (1) MX2013004371A (enExample)
PH (1) PH12013500761A1 (enExample)
RU (1) RU2013123062A (enExample)
SG (1) SG189935A1 (enExample)
WO (1) WO2012052463A1 (enExample)
ZA (1) ZA201303656B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
CN111315239A (zh) * 2017-11-21 2020-06-19 雀巢产品有限公司 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
WO2020163188A1 (en) * 2019-02-08 2020-08-13 Imbria Pharmaceuticals, Inc. Compositions containing n-acetylcysteine conjugated to a tca cycle intermediate
EP4049672A4 (en) * 2019-10-25 2023-11-29 Ajinomoto Co., Inc. Muscle quality improvement agent
US20260102441A1 (en) 2022-09-30 2026-04-16 Evonik Operations Gmbh Probiotic composition for the treatment of malnutrition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
JPS62286923A (ja) * 1986-06-04 1987-12-12 Takao Shinoda 貧食作用増強剤
JPH05294833A (ja) * 1991-04-15 1993-11-09 Takeda Chem Ind Ltd ビタミン含有保健剤
WO1993002682A1 (en) 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
DE4229166A1 (de) * 1992-09-01 1994-03-03 Deutsches Krebsforsch Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
FR2711529B1 (fr) 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
US5627152A (en) * 1995-01-18 1997-05-06 Telluride Pharmaceutical Corporation Method for increasing bodyweight
US5770217A (en) 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
RO119122B1 (ro) * 1998-02-02 2004-04-30 Dumitru Dobrescu Medicament geriatric
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
WO2006134135A2 (en) 2005-06-14 2006-12-21 Nestec S.A. Nutritional method for elderly people
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤
JP2009001507A (ja) 2007-06-19 2009-01-08 Ss Pharmaceut Co Ltd 体脂肪減少剤およびその利用
WO2009157759A1 (en) * 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
TWI515005B (zh) * 2008-09-12 2016-01-01 2458781加拿大公司 在接受化療或放療的患者中應用富含半胱胺酸之乳清衍生蛋白以增進患者存活時間
SG185344A1 (en) 2008-10-17 2012-11-29 Nestec Sa Whey protein compositions, methods and uses

Also Published As

Publication number Publication date
EP2444083A1 (en) 2012-04-25
MX2013004371A (es) 2013-08-27
BR112013009709A2 (pt) 2016-07-19
ZA201303656B (en) 2014-11-26
US9233090B2 (en) 2016-01-12
CN103269697A (zh) 2013-08-28
PH12013500761A1 (en) 2017-08-23
SG189935A1 (en) 2013-06-28
AU2011317627B2 (en) 2016-06-02
WO2012052463A1 (en) 2012-04-26
CA2815109C (en) 2020-03-24
DK2629769T3 (en) 2018-01-02
JP2014504261A (ja) 2014-02-20
EP2629769A1 (en) 2013-08-28
US20130225486A1 (en) 2013-08-29
ES2654344T3 (es) 2018-02-13
CA2815109A1 (en) 2012-04-26
AU2011317627A1 (en) 2013-05-23
JP6160832B2 (ja) 2017-07-12
EP2629769B1 (en) 2017-10-04

Similar Documents

Publication Publication Date Title
Khora Marine fish-derived bioactive peptides and proteins for human therapeutics
JP5315996B2 (ja) 総合経腸栄養組成物
ES2314485T3 (es) Composiciones que comprenden acido pantotenico o derivados del mismo y su uso para estimular el apetito.
RU2012139658A (ru) Композиции и способы для доставки питательных веществ
CA2815109C (en) Cysteine and food intake
JP2024122087A (ja) 遊離アミノ酸吸収促進剤及び遊離アミノ酸の吸収を促進する方法
JP2014504261A5 (enExample)
Kulkarni et al. L-Glutamic acid and glutamine: Exciting molecules of clinical interest
CN1571637A (zh) 胱硫醚的用途
JP2008088162A (ja) 睡眠補助剤および睡眠補助食品
WO2004060081A8 (en) A method of improving nutrient utilisation by a mammal and a composition for use therein
JP2013166719A (ja) Ampk活性化剤
Yavuz et al. The importance of animal proteins for human nutrition
CN113491334B (zh) 营养组合物
Rashmi et al. Influence of dietary molecules on human health: Whey proteins
WO2013004865A3 (es) Suplemento alimenticio, método para incrementar la masa bacteriana en el rumen de un rumiante y preparado alimenticio y usos correspondientes
EP2745710A1 (en) A nutraceutical compound
US20070269490A1 (en) Material for Processed Food for Weight Reduction Diets and Weight Reduction Dietary Processed Food Using Thereof
Holvik et al. Risk Assessment of" Other Substances"–L-proline
Tell et al. Risk Assessment of" Other Substances"–L-arginine and Arginine Alpha-ketoglutarate
Skålhegg et al. Risk Assessment of" Other Substances"–L-leucine, L-isoleucine and L-valine, the Branched Chain Amino Acids (BCAA)
CN104856027A (zh) 一种儿童健脑保健品
CN104126745A (zh) 一种营养减肥食品
JP2016074617A (ja) 脂肪蓄積抑制剤
Rema et al. Dietary hempseed meal and hempseed oil enhanced growth performance in juvenile turbot (Scophthtalmus maximus)

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20141020